FEATURED STORIES
RECENT NEWS
Viridian Capital Advisors Releases Deal Tracker for Week Ended July 21, 2017
July 25, 2017 – Viridian Capital Advisors released its Deal Tracker for the week ended July 21, 2017. Total capital raised year-to-date in the cannabis sector is up to $1.325 billion.
Continue readingAlliance Negotiates Equity Partnership for Licensed Cultivation Facility in City of Long Beach
July 27, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to announce that the Company has entered into negotiations with a private company for an equity partnership for a licensed...
Continue readingNew Health Canada Regulations Allow for Substantial Increase in MYM Vault Size
Vancouver, B.C., July 27, 2017 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is extremely pleased to announce that Health Canada has introduced new regula-tions that will allow for a substantial increase in production at the Laval location vault size....
Continue readingGolden Leaf CEO William Simpson Issues Letter to Shareholders
TORONTO, ON--(Marketwired - July 27, 2017) - Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH) (OTCQB: GLDFF), a leading cannabis oil solutions company built around recognized brands, is issuing the letter below to shareholders. To Our Valued Shareholders:...
Continue readingMedical Marijuana, Inc. Subsidiary HempMeds® Mexico Discusses Therapeutic Benefits of Cannabis During Annual International League Against Epilepsy Meeting
Renowned Mexican Neurologist Presents on Effects of Real Scientific Hemp Oil-X™ (RSHO-X™) in Treating Children with Severe Epilepsy SAN DIEGO, July 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today...
Continue readingCara Therapeutics to Announce Second Quarter 2017 Financial Results on August 3, 2017
STAMFORD, Conn., July 27, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid...
Continue readingInMed Announces Publication in European Journal of Pain
Vancouver, BC – July 27, 2017 - InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today the publication of...
Continue readingMarijuana Company of America Completes $250,000 Investment in MoneyTrac Technology
Escondido, CA — (July 27, 2017) – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative cannabis and hemp corporation, is pleased to announce that it has completed an investment of $250,000 into MoneyTrac Technology, Inc. (“MTT”), a...
Continue readingCanopy Growth Corporation Completes Previously Announced $25M Private Placement Financing
July 27, 2017 SMITHS FALLS, ON – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) is pleased to announce that it has completed its previously announced private placement with one investor (the “Offering”) of common shares (the “Shares”)....
Continue readingLegislative Updates – HR 3391 Introduced in the House
July 26, 2017 – Representative Any Harris (R-MD) introduced H.R. 3391: To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes. There are currently three cosponsors to...
Continue readingABcann Global Provides Construction and Expansion Update
OTTAWA, July 26, 2017 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSX-V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) (the “Company”) is pleased to provide an update on the Company's construction and expansion timelines for its Vanluven and Kimmett facilities, both located...
Continue readingValens Groworks Announces Private Placement, Insider Participation
Vancouver, B.C., July 26, 2017 – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a vertically integrated provider of cannabis products, is pleased to announce a non-brokered private placement of up to 4,000,000 units (the “Units”) at a price of $1.00 per...
Continue readingMOST POPULAR
Hemp Industries Association Responds to DEA Final Rule… The HIA has issued its position on the Drug Enforcement… December 19, 2016 
Canna Equities Interviews Michael Mellano, CEO, Green… February 8, 2018 
More Anti-Science From the Administration May 31, 2017
NEW ISSUES
Canna Equities Month in Review Newsletter Signup
Enter your email address below to sign up for our monthly newsletter featuring developments and analysis of the cannabis industry and related capital markets. You can view a recent newsletter example by clicking here.